BUDGET IMPACT ANALYSIS OF AZTREONAM-AVIBACTAM (ATM-AVI) FOR THE TREATMENT OF INFECTIONS CAUSED BY CONFIRMED AND SUSPECTED METALLO B-LACTAMASE (MBL)-PRODUCING ENTEROBACTERALES IN ITALY

被引：0
|
作者：
Falcone, M. [1 ]
Bao, X. [2 ]
Woodcock, F. [2 ]
Di Virgilio, R. [3 ]
Pereira, Vidal M. A. [3 ]
Kantecki, M. [4 ]
Gheorghe, M. [5 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Source Hlth Econ, London, England
[3] Pfizer Italia Srl, Rome, Italy
[4] Pfizer, Paris, France
[5] Pfizer Inc, Bucharest, Romania
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE230
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 9 条
  • [1] In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
    Wang, Wen
    Huang, Shifeng
    Zou, Chunhong
    Ding, Yanhui
    Wang, Huijuan
    Pu, Shuli
    Liao, Yunfeng
    Du, Hong
    Wang, Deqiang
    Chen, Liang
    Niu, Siqiang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [2] Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae
    Wong, Darren W.
    ANTIBIOTICS-BASEL, 2024, 13 (08):
  • [3] Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
    Falcone, Marco
    Daikos, George L.
    Tiseo, Giusy
    Bassoulis, Dimitrios
    Giordano, Cesira
    Galfo, Valentina
    Leonildi, Alessandro
    Tagliaferri, Enrico
    Barnini, Simona
    Sani, Spartaco
    Farcomeni, Alessio
    Ghiadoni, Lorenzo
    Menichetti, Francesco
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : 1871 - 1878
  • [4] In vitro activity of aztreonam-avibactam and comparators against Metallo- ,B-Lactamase-producing Enterobacterales from ATLAS Global Surveillance Program, 2016-2020
    Rossolini, Gian Maria
    Arhin, Francis F.
    Kantecki, Michal
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 123 - 131
  • [5] Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections-In Vitro Susceptibility Testing
    Brauncajs, Malgorzata
    Bielec, Filip
    Malinowska, Marlena
    Pastuszak-Lewandoska, Dorota
    PHARMACEUTICALS, 2024, 17 (03)
  • [6] Activity of aztreonam/avibactam against metallo-,B-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42,B-lactamase in Escherichia coli
    Livermore, David M.
    Mushtaq, Shazad
    Vickers, Anna
    Woodford, Neil
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 61 (05)
  • [7] Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria
    Emeraud, Cecile
    Escaut, Lelia
    Boucly, Athenais
    Fortineau, Nicolas
    Bonnin, Remy A.
    Naas, Thierry
    Dortet, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [8] In Vitro Activities of Aztreonam-avibactam and Comparator Agents against Metallo-,B-lactamase-producing Enterobacterales Collected in the Middle East and Africa, ATLAS Global Surveillance Program, 2018-2022
    Estabrook, Mark
    Stone, Gregory
    Sahm, Daniel
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [9] Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales
    Merad, Yanis
    Conrad, Anne
    Brosset, Sophie
    Schmidt, Axel
    Hanriat, Camille
    Lustig, Sebastien
    Laurent, Frederic
    Kolenda, Camille
    Roussel-Gaillard, Tiphaine
    Batailler, Cecile
    Ferry, Tristan
    FRONTIERS IN MEDICINE, 2023, 10
1